Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.

作者: K Milde-Langosch , A-M Bamberger , G Rieck , D Grund , G Hemminger

DOI: 10.1038/SJ.BJC.6602655

关键词:

摘要: Extracellular-regulated kinases (ERK1, ERK2) play important roles in the malignant behaviour of breast cancer cells vitro. In our present study, 148 clinical samples (120 cases with follow-up data) were studied for expression ERK1, ERK2 and their phosphorylated forms p-ERK1 p-ERK2 by immunoblotting, p-ERK1/2 corresponding paraffin sections was analysed immunohistochemistry. The results correlated established histological prognostic parameters, data seven cell-cycle regulatory proteins as well MMP1, MMP9, PAI-1 AP-1 transcription factors, which had been before. High determined immunoblots significantly a low frequency recurrences infrequent fatal outcome (P=0.007 0.008) an independent indicator long relapse-free overall survival multivariate analysis. By immunohistochemistry, strong p-ERK staining tumour associated early stages (P=0.020), negative nodal status (P=0.003) recurrence-free (P=0.017). contrast, unphosphorylated ERK1 not except positive correlation oestrogen receptor status. Comparison formerly cell-cycle- invasion-associated corroborates conclusion that activation is enhanced proliferation invasion mammary carcinomas.

参考文章(34)
Qiang Shen, Powel H. Brown, Novel agents for the prevention of breast cancer: Targeting transcription factors and signal transduction pathways Journal of Mammary Gland Biology and Neoplasia. ,vol. 8, pp. 45- 73 ,(2003) , 10.1023/A:1025783221557
Pelech S, Matthewson C, Salh B, Owen D, Flint J, Ahluwalia M, Marotta A, Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer. Anticancer Research. ,vol. 19, pp. 731- 740 ,(1999)
Edwin Dublin, Andrew Hanby, Neera K. Patel, Rachael Liebman, Diana Barnes, Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast Carcinoma: Fibroblastic Expression Has Strong Associations with Tumor Pathology American Journal of Pathology. ,vol. 157, pp. 1219- 1227 ,(2000) , 10.1016/S0002-9440(10)64637-8
Maria Seddighzadeh, Jian-Nian Zhou, Ulrike Kronenwett, Maria C. Shoshan, Gert Auer, Margareta Sten-Linder, Björn Wiman, Stig Linder, ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation. Clinical & Experimental Metastasis. ,vol. 17, pp. 649- 654 ,(1999) , 10.1023/A:1006741228402
Peter Collins, Carolyn Webb, Estrogen hits the surface Nature Medicine. ,vol. 5, pp. 1130- 1131 ,(1999) , 10.1038/13453
Julio A. Aguirre-Ghiso, Liliana Ossowski, Yeriel Estrada, David Liu, ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK Cancer Research. ,vol. 63, pp. 1684- 1695 ,(2003)
Anne Brunet, Danièle Roux, Philippe Lenormand, Stephen Dowd, Stephen Keyse, Jacques Pouysségur, Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry The EMBO Journal. ,vol. 18, pp. 664- 674 ,(1999) , 10.1093/EMBOJ/18.3.664
Michael E. Kupferman, M. Elizabeth Fini, William J. Muller, Randal Weber, Yi Cheng, Ruth J. Muschel, Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. American Journal of Pathology. ,vol. 157, pp. 1777- 1783 ,(2000) , 10.1016/S0002-9440(10)64815-8